Patents Assigned to SMITHKLINE BEECHAM PHARMCO PUERTO RICO INCORPORATE
  • Publication number: 20070141146
    Abstract: An oral dosage form that provides controlled release of an active pharmaceutical agent, 5 -[4-[2-(N-methyl-N-(2 pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (hereinafter ‘Compound A’) or a pharmaceutically acceptable salt or solvate thereof in different body environments, a process for the preparation of such an oral dosage form, and the use of such a dosage form in medicine.
    Type: Application
    Filed: October 21, 2004
    Publication date: June 21, 2007
    Applicant: SMITHKLINE BEECHAM PHARMCO PUERTO RICO INCORPORATE
    Inventors: Vincenzo Re, Laurence Robinson